This Review explores the challenges and opportunities of taking CARs down new therapeutic roads, in terms of developing chimeric antigen receptors (CARs) for treating infectious disease, autoimmunity and transplant rejection.
- Colby R. Maldini
- Gavin I. Ellis
- James L. Riley